Day: October 3, 2025

Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference – October 8-9, 2025

Showcasing Disruptive Sublingual Drug Delivery Technology with Lead Program Targeting H2 2025 FDA Submission for Sublingual AspirinHighlighting Key 2026 Milestones...

error: Content is protected !!